DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAGP

Impetigo and ecthyma

Essential points for quick revision.

Synopsis

Distinguish superficial impetigo from deeper ulcerative ecthyma and important blistering mimics, use hygiene and finite antimicrobial treatment proportionately, and investigate non-response or recurrence.

  • Non-bullous impetigo begins with thin-roofed vesicles or pustules that become honey-coloured crusted erosions, commonly around the nose, mouth and exposed limbs.
  • Bullous impetigo produces larger flaccid blisters, often on trunk or flexures, and warrants oral treatment because toxin-producing staphylococci are involved.
  • Ecthyma has an adherent dark crust over a punched-out ulcer extending into dermis; swab and use systemic treatment rather than treating it as a superficial spot.

Key red flags

Systemic toxicity, rapidly spreading pain or erythema, extensive bullae, mucosal involvement, periorbital disease, immunocompromise, neonatal infection, dehydration or suspected staphylococcal scalded-skin syndrome requires urgent assessment.

Invasive extension

Rapidly expanding warmth, swelling and pain beyond lesions, fever or physiological instability indicates cellulitis or sepsis and needs urgent care.

Investigation priorities

01
Clinical morphology and extent assessmentFirst step

Classify non-bullous, bullous, ecthyma or invasive disease and choose treatment route.

Management branches

Localised non-bullousMinimise antimicrobial exposure

A small area of superficial honey-crusted lesions occurs without bullae, systemic illness or high complication risk.

  1. Offer hydrogen peroxide 1% cream two or three times daily for five days and explain local irritation and eye avoidance.
  2. If unsuitable or ineffective, choose a five-day topical antibiotic according to NICE and local resistance, rather than combining products.

Key medicines

Hydrogen peroxide 1% creamApply two or three times daily for five days to localised non-bullous impetigo, avoiding eyes and mucosa.
Fusidic acid 2% creamApply three times daily for five days when hydrogen peroxide is unsuitable or ineffective; extend to seven days only by clinical judgement.
Open full textbook Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom